Home
Funding Areas
About Us
Duchenne muscular dystrophy is the most common, severe, and life-threatening form of the degenerative neuromuscular disease affecting only boys, and the FDA just approved a drug that could change the lives of boys with the disease, NBC News reports.
Vamorolone, developed at Children's National Hospital in Washington, DC, is a steroidal-type, anti-inflammatory drug that has been shown in clinical trials to improve muscle strength and stature in boys with DMD without the side effects of steroids, such as weakened bones and stunted growth.
"Throughout my career, I have treated children with DMD, and I have seen over time how their shorter heights and brittle bones impact them physically and emotionallyin terms of their self-esteem and ability to participate in activities," the hospital's then-chief academic officer says in a press release.
"This drug should help these boys function more effectively and prevent certain long-term complications."
Vamorolone was developed using a different business model and drug development approach, including partnerships with the National Institutes of Health, the Department of Defense, the European Commission, and more than a dozen international nonprofit foundations.
In clinical trials, daily treatment with vamorolone improved muscle strength and stature with results comparable to prednisolone, but without
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
'Safety, compassion, innovation': Beaufort Memorial honors top staff at Bemmy Awards.The Quality Services department took home the award for Department of the Year at BeaufortMemorial Hospital's...more
This ranking recognizes the leading children's hospitals in the U.S., featuring the top 50 hospitals.Cleveland Clinic Children's placed in all eight pediatric subspecialities: Cardiology and Cardiac...more
Mackinac Policy Conference left early childhood education off this year's agenda.By 2027, make Detroit a city that puts young children and families first, says James Ribbron, executive director of...more
Investing in tech to help children and communities thrive | Takeda Stories.How our Global CSR Program helped empower diverse entrepreneurs to innovate health solutions.29 Digital public goods...more
Greg Bourke is the author of "Gay, Catholic, and American: My Legal Battle for Marriage Equality and Inclusion" Bourke spoke at the Yale School of Management's Social Impact Lab.Bourke's final advice...more
Tesla plans to deploy a small fleet of robotaxis in Austin in the coming weeks.Tesla FSD 13.2.9 will still run a kid down while illegally blowing past a stopped school bus with red lights flashing...more
Awarded funding will support a wide range of activities between now and September 30, 2025.The FCCN initiative, supported by $85,000 in grant funding, will help build and sustain a Family Child Care...more
The Delivering Innovative Vocational Education through Virtual Reality Technology new workforce training program aimed at preparing individuals with disabilities for the program.DIVE-VRT delivers...more
Children are growing up surrounded by screens, apps, and smart devices.Being intentional about tech use goes a long way toward deepening interest in tech and creating meaningful experiences.Creating...more
Safeguarding innovation and trade secrets in American AI leadership Safeguarded innovation andtrade secrets in U.S.AI leadership.Testimony was given before the House Judiciary Subcommittee on Courts,...more
Children News from...
Becton, Dickinson and Company
Johnson Foundation
Robert Wood Johnson Foundation
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
